Gapping up
In reaction to earnings/guidance:
- KRUS +8.3%, CAG +2.4%, RGP +0.5%
Other news:
- DRS +5.8% (awarded $1.0 bln contract)
- WBX +5.7% (stock offering)
- JNJ +2.9% (paying $8.9 bln in talc litigation claims)
- BBDC +2.8% (CFO steps down; appoints new CFO)
- GRTS +2.8% (Presentations Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 at ECCMID 2023)
- AGO +2.7% (Assured Guaranty's Asset Management Business to combine with Sound Point Capital Management)
- HUT +2.2% (reports 131 Bitcoin mined in March)
- PLTR +2% (Palantir Technologies and Microsoft (MSFT) expand cloud partnership to public sector)
- BLU +2% (Positive Results from its Phase 1 Bioavailability Equivalence Study)
- AUPH +1.9% (announces promising topline data from renal biopsy sub-study of the aurora trial)
- PBI +1.8% (Hestia Capital Management calls for company to replace CEO according to WSJ)
- LDI +1.3% (Announces Settlement and Cooperation Agreement with Anthony Hsieh)
Analyst comments:
- LTHM +2.9% (upgraded to Buy from Neutral at BofA Securities)
- SLM +2.2% (upgraded to Overweight from Underweight at Morgan Stanley)
- SEE +2% (upgraded to Buy from Neutral at UBS)